JPRN-UMIN000015375
Completed
未知
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea - Levofloxacin-containing sequential therapy in Korea
ConditionsHelicobacter pylori infection
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Helicobacter pylori infection
- Sponsor
- Severance Hospital, Yonsei University
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) patients with previous H. pylori eradication therapy; (2\) patients treated with H2 receptor antagonist, PPI, and antibiotics in the previous 4 weeks, or nonsteroidal anti\-inflammatory drug (NSAID) in the previous 2 weeks; (3\) pregnant or lactating women; (4\) patients who suffered from serious diseases such as severe liver disease, renal disease, and cerebrovascular disease; (5\) patients who had a drug allergy to the study drugs; and (6\) patients with previous gastric surgery.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Efficacy and Safety of treatment with Levofloxacin for Community-acquired PneumoniaCommunity-acquired pneumonia in adultsJPRN-UMIN000008677Second Division, Department of Internal Medicine, Hamamatsu university school of medicine300
Recruiting
Not Applicable
Comparison of Levofloxacin/Colistin with Levofloxacin/high dose Ampicillin-sulbactam infusion in treatment of Ventilator-Associated Pneumonia due to multi drug resistant AcinetobacterIRCT20120703010178N15Shahid Beheshti University of Medical Sciences56
Completed
Phase 2
Comparing the effect of levofloxacin with azithromycin in improving pulmonary function of patients with bronchiectasisIRCT20100102002954N28Shahroud University of Medical Sciences72
Recruiting
Phase 1
Efficacy of levofloxacin and colistin inhalation form in treatment of pneumoniaVentilator associated pneumonia (VAP) caused by multidrug resistant pathogens.Ventilator associated pneumoniaJ95.851IRCT20100107003014N26Mazandaran University of Medical Sciences70
Recruiting
Phase 4
Pharmacokinetic study and safety of levofloxacin in pediatric tuberculosis treatmentMulti-drug resistant tuberculosisIsoniazid resistant tuberculosispatient with toxicity from the first line antituberculosisMDR-TBHr-Toxicity from the first line anti-LevofloxacinTCTR20190515001Center of Excellence for Pediatric Infectious Diseases and Vaccines20